Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000950170-25-036363
Filing Date
2025-03-10
Accepted
2025-03-10 16:31:17
Documents
5
Effectiveness Date
2025-03-10

Document Format Files

Seq Description Document Type Size
1 S-8 okur_s-8_20250310_no_xbr.htm S-8 107932
2 EX-5.1 okur-ex5_1.htm EX-5.1 18203
3 EX-23.1 okur-ex23_1.htm EX-23.1 4160
4 EX-FILING FEES okur-exfiling_fees.htm EX-FILING FEES 50261
5 GRAPHIC img201043379_0.jpg GRAPHIC 18643
  Complete submission text file 0000950170-25-036363.txt   207528
Mailing Address 6707 WINCHESTER CIRCLE, SUITE 400 BOULDER CO 80301
Business Address 6707 WINCHESTER CIRCLE, SUITE 400 BOULDER CO 80301 (720) 307-2892
OnKure Therapeutics, Inc. (Filer) CIK: 0001637715 (see all company filings)

EIN.: 472309515 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-285680 | Film No.: 25724218
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)